Basit öğe kaydını göster

Flupirtine may stop the progressive course of subacute sclerosing panencephalitis

dc.contributor.authorTatli, Burak
dc.contributor.authorEkici, Baris
dc.contributor.authorOzmen, Meral
dc.date.accessioned2021-03-03T19:34:01Z
dc.date.available2021-03-03T19:34:01Z
dc.date.issued2010
dc.identifier.citationTatli B., Ekici B., Ozmen M., "Flupirtine may stop the progressive course of subacute sclerosing panencephalitis", MEDICAL HYPOTHESES, cilt.75, sa.6, ss.576-577, 2010
dc.identifier.issn0306-9877
dc.identifier.otherav_553d1341-54a5-4ca0-81e3-03297530ff1b
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/60276
dc.identifier.urihttps://doi.org/10.1016/j.mehy.2010.07.035
dc.description.abstractSubacute sclerosing panencephalitis (SSPE) is a progressive devastating disease. Along with the slow measles virus infection, apoptotic cell death has shown to be one of the major mechanisms at the pathogenesis. Volume reduction in frontotemporal cortex has seen in patients at early stages of disease. At present, there is no effective treatment to completely cure SSPE. Oral isoprinosine and intrathecal or intraventricular alpha-interferon are anti viral therapies with limited success.
dc.language.isoeng
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.titleFlupirtine may stop the progressive course of subacute sclerosing panencephalitis
dc.typeMakale
dc.relation.journalMEDICAL HYPOTHESES
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume75
dc.identifier.issue6
dc.identifier.startpage576
dc.identifier.endpage577
dc.contributor.firstauthorID198478


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster